Brand Name: IMJUDO
Generic Name: tremelimumab
Primary Class: CTLA-4-directed Antibody Interactions [MoA]
SPL Set ID: 6690679c-be2f-4588-a2e4-89fff74dd6be view on Dailymed | RXCUI: 2619317
Manufacturer Name: AstraZeneca Pharmaceuticals LP
| Package NDC | Description |
|---|---|
| 0310-4505-25 | 1 VIAL in 1 CARTON (0310-4505-25) / 1.25 mL in 1 VIAL |